Results 61 to 70 of about 1,476,378 (238)

Examining Tertiary Healthcare Quality Under Asset Leasing, Performance‐Based Financing, and Social Impact Bonds: The Role of Government Stewardship in a Cross‐Sectional Quantitative Study in Kenya

Health Science Reports
Background and Aims Tertiary healthcare systems in low‐ and middle‐income countries persistently suffer quality gaps due to inefficient financing and governance.
Ezekiel Karino, James Ndegwa, Vincent Were   +2 more
doaj   +1 more source

Domestic Resource Mobilisation for Sustainable Healthcare Financing in Nigeria: A Review

Nigerian Postgraduate Medical Journal
Domestic resource mobilisation (DRM) is vital for achieving sustainable healthcare financing in Nigeria, where dependence on external funding and oil revenues has long hindered health sector progress.
Amina Idris Bello, Maryam Abimbola Jimoh, Abdul-Rasheed Olalekan Tijani, Hafsat Abolore Ameen   +3 more
doaj   +1 more source

Self-Rated Health Trajectories among Married Americans: Do Disparities Persist over 20 Years?

Journal of Aging Research, 2018
The purpose of this study is to understand self-rated health (SRH) trajectories by social location (race/ethnicity by gender by social class) among married individuals in the United States. We estimate multilevel models of SRH using six observations from
Terceira A. Berdahl, Julia McQuillan
doaj   +1 more source

Sources of health care financing in Poland and Germany

Prawo Budżetowe Państwa i Samorządu, 2018
This paper focuses on public sources of a healthcare financing in Poland and in Germany. These systems are based primarily on the health insurance contributions. In Poland and in Germany a healthcare is also financed from state budgets. Author identified
Paweł Lenio
doaj   +1 more source

Accelerated Reforms in Healthcare Financing: The Need to Scale up Private Sector Participation in Nigeria [PDF]

International Journal of Health Policy and Management, 2014
The health sector, a foremost service sector in Nigeria, faces a number of challenges; primarily, the persistent under-funding of the health sector by the Nigerian government as evidence reveals low allocations to the health sector and poor health system
Ufuoma John Ejughemre
doaj   +1 more source

Ligand‐dependent transcriptional heterogeneity in cell cycle gene expression delays G1/S entry

FEBS Letters, EarlyView.
EGF and HRG induce distinct G1/S progression programs in ErbB2‐amplified BT474 breast cancer cells. Despite activating the potent ErbB2–ErbB3 heterodimer, HRG does not accelerate cell‐cycle entry. Instead, EGF promotes earlier restriction‐point passage via ERK–FOS signaling, whereas HRG activates the AKT–MYC axis, driving transcriptional heterogeneity ...
Ririn Rahmala Febri, Ayaka Nagasato‐Ichikawa, Keita Iida, Shuhei Kimura, Akira Imamoto, Mariko Okada   +5 more
wiley   +1 more source

Analysis of the impact of public-private partnership on the development of the domestic medical industry

Вестник университета
The development of the social sphere in the country depends on the development of healthcare and medical industry, which serve as its basis, both at the municipal and regional levels, and show the level of its development.
I. R. Elistratov
doaj   +1 more source

The Distributional Impact of Healthcare Financing in Nigeria: A Case Study of Enugu State [PDF]

The deregulation of healthcare financing and supply in Nigeria has shifted the healthcare system towards competitive market ideals. Households' decision to utilize healthcare is identical with healthcare financing.
William Munpuibeyi Fonta, Hyacinth Ementa Ichoku   +1 more
core  

Healthcare Financing in Saudi Arabia: A Comprehensive Review

Saudi Vision 2030 is a game-changer for all aspects of the economy, including healthcare. This article provides a comprehensive overview of healthcare financing in the Kingdom of Saudi Arabia (KSA).
Kesavan Sreekantan Nair, Alharbi, Ali H., Ali H. Alharbi, Mughal, Yasir Hayat, Albejaidi, Fahad, Yasir Hayat Mughal, Nair, Kesavan Sreekantan, Fahad Albejaidi   +7 more
core   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source